Get up to speed with the latest psychedelic developments. Short daily – more personal – articles on psychedelics, from industry news to psychedelic research.

The take home messages from the Interdisciplinary Conference on Psychedelic Research 2022. Novel results, DMT, and a personal note.
Researchers associated with Mindbloom just published an article arguing that at-home ketamine-assisted therapy is not only safe but led to improvements (<50%) in depression and anxiety in 62% of participants.
Psychedelic therapy is going mainstream - it won’t be long before these therapies are rolled out in clinics across the globe once the regulations around these substances are changed.
Health systems are unprepared to offer and meet the demand for psychedelic-assisted therapy - we can start to prepare now.
The legal issues and stigma surrounding psychedelics have deterred many traditional sources from funding - now, things are changing.
The next generation of psychedelics is already here – let's take a look at the advantages and disadvantages.
Despite psychedelics remaining highly controlled – it hasn’t deterred investors and a sizeable market has developed.
Anyone following the rise of psychedelic science in recent years should be all too familiar with the efforts to patent various aspects of the psychedelic experience – from the drug themselves to methods of administering them.
Psychedelic research is going from strength to strength. With roughly 50 psychedelic research papers published every month and the abundance of start-ups looking to turn psychedelics into viable therapy options - we’ve come a long from the handful of papers published each year in the early 2010s.
Despite the resurgence in psychedelic research in recent years – psychedelics are notoriously difficult and expensive to work with. Why is this the case and how do we overcome it?

Blossom’s Bits

We examine what is happening in the psychedelic landscape and make this accessible in short daily articles. Some articles put the news into context, others excerpt our long-form reports to make a key insight visible. At other times, the bits serve as a place to share an interview, viewpoint, or experience. All to keep you in the loop on what’s happening in psychedelics as medicine.

Become a psychedelic insider!

With a free Blossom membership you will always be in the know.

📰 Weekly newsletter about the psychedelic research

✔️ Unlimited access to our database and original articles

🖊️ Add (private) notes and comments to each page

Make an account